Gene Therapy Market is estimated to be US$ 58.90 billion by 2034 at a CAGR 20.6% during the forecast period

Gene therapy means fixing a working gene to an individual who features a damaged gene.The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with a working copy of the gene. Genes are the composition of an acid which is consists of essential information which is used in the protein production that is necessary for best possible functioning of body. This acid is deoxyribonucleic acid. When proteins are made imperfectly then it is termed as gene mutations, which results into the genetic disorder Gene therapy is projected to introduce healthy gene within the damaged cells that are used to counteract for various abnormal genes. They are also intended to make proteins of interest. Gene Therapy Market Size was valued at US$ 10.73 billion in 2024 and is projected to grow at a CAGR of 20.6%to reach US$ 58.90 billion by 2034.

The report "Gene Therapy Market Size, Share by Gene Therapy Type (Germline Gene Therapy and Somatic Gene Therapy), By Type of Vector (Viral Vector and Non-viral Vector), By Disease Indication (Cardio Vascular Diseases, Cancer, Genetic Disorders, Neuro Disorders, Infectious Diseases, and Others), and By Region – Market Trends, Analysis and Forecast till 2034”

Key Highlights:

• In 2021, NJII announced its partnership with McKinsey & Company in the launch of a new center to advance operations and manufacturing excellence in cell and gene therapy (CGT).

Analyst View:

Rising demand for gene therapy owing to growing number of patients suffering from cancer, various chronic diseases, hereditary disorders, and HIV is major factor driving growth of the target market, currently. Furthermore, increasing technological developments, innovations, and clinical and pre-clinical trials are some among the major factors expected to propel growth of the gene therapy market over the forecast period.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Gene Therapy Market Size, Share by Gene Therapy Type (Germline Gene Therapy and Somatic Gene Therapy), By Type of Vector (Viral Vector and Non-viral Vector), By Disease Indication (Cardio Vascular Diseases, Cancer, Genetic Disorders, Neuro Disorders, Infectious Diseases, and Others), and By Region – Market Trends, Analysis and Forecast till 2034”

Key Market Insights from the report:

Gene Therapy Market Size was valued at US$ 10.73 billion in 2024 and is projected to grow at a CAGR of 20.6%to reach US$ 58.90 billion by 2034. The gene therapy market is segmented on the basis of gene therapy type, type of vector, disease indication, and geography.

• By Therapy Type, the market is segmented into Germline Gene Therapy and Somatic Gene Therapy.
• By Type of Vector, the market is segmented into Viral Vector and Non-viral Vector.
• By Disease Indication, the market is segmented into Cardio Vascular Diseases, Cancer, Genetic Disorders, Neuro Disorders, Infectious Diseases, and Others.
• By Region, the Diabetic Neuropathy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape:

The Key players operating in the market of gene therapy market includes GlaxoSmithKline plc, Bluebird Bio, Inc., Adaptimmune Therapeutics plc, Celgene Corporation, Shanghai Sunway Biotech Co. Ltd., Merck KGaA, Transgene SA, and OncoGenex Pharmaceuticals, Inc.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

To know more

Contact Us:

Sales

Prophecy Market Insights

U.S: 1 860 531 2574

RoW: 91 7775049802

Email- [email protected]

Website- www.prophecymarketinsights.com

Blog- www.prophecyjournals.com